Beauty Farm Medical and Health Industry Inc. (2373) announced that on October 23, 2025, it repurchased 65,000 shares on the market at an average transaction price of approximately HK$30.33 per share, for a total amount of about HK$1,971,240. According to the announcement, from October 15, 2025 to the date of this disclosure, the company has repurchased a total of 325,000 shares, with an aggregate consideration of approximately HK$10,394,950.

The board indicated that the current trading price of the shares does not reflect the intrinsic value or the company’s business prospects and believes the repurchase reinforces confidence in the firm’s long-term value. The action was conducted under the general mandate granted at the company’s annual general meeting on June 27, 2025, permitting the repurchase of up to 23,579,556 shares. The announcement also states that any future share repurchases will depend on market conditions, and there is no guarantee regarding timing, quantity, or price.